Skip to main content

Table 1 Association between viral load, antiretroviral adherence profile and the adoption of COVID-19 pandemic preventive behaviour status among PLHIV during the first wave of the pandemic (N = 680)

From: Correction: Differences in adoption of COVID-19 pandemic related preventive behaviour by viral load suppression status among people living with HIV during the first wave of the pandemic

Variables

Total

Physical distancing

Face mask

Handwashing

Work remotely

No

Yes

AOR; 95% CI; p value

No

Yes

AOR; 95% CI; p value

No

Yes

AOR; 95% CI; p value

No

Yes

AOR; 95% CI; p value

N = 680

221 (32.5%)

459 (67.5%)

99 (14.6%)

581 (85.4%)

132 (19.4%)

548 (80.6%)

540 (79.4%)

140 (20.6)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

Viral load

 Undetectable

488 (71.8)

157 (32.2)

331 (67.8)

1

56 (11.5)

432 (88.5)

1

86 (17.6)

402 (82.4)

1

389 (79.7)

99 (20.3)

1

 Detectable

192 (28.2)

64 (33.3)

128 (66.7)

1.06; 0.72–1.55; p = 0.74

43 (22.4)

149 (77.6)

0.44; 0.28–0.69; p < 0.01

46 (24.0)

146 (76.0)

0.64; 0.42–0.97; p = 0.03

151 (78.6)

41 (21.4)

0.99; 0.64–1.53; p = 0.98

Adherence to ART

 No

151 (22.2)

53 (35.1)

98 (64.9)

1

23 (15.2)

128 (84.8)

1

30 (19.9)

121 (80.1)

1

107 (70.9)

44 (29.1)

1

 Yes

529 (77.8)

168 (31.8)

361 (68.2)

1.04; 0.69–1.58; p = 0.83

76 (14.4)

453 (85.6)

0.99; 0.57–0.71; p = 0.98

102 (19.3)

427 (80.7)

1.11; 0.69–1.81; p = 0.65

433 (81.9)

96 (18.1)

0.60; 0.38–0.94; p = 0.02

Age

39.9(11.3)

39.1 (11.6)

40.3 (11.2)

1.01; 1.00–1.03; p = 0.38

40.9 (11.3)

39.7 (11.3)

0.99; 0.97–1.00; p = 0.51

39.3 (10.1)

40.0 (11.6)

1.07; 0.98–1.02; p = 0.46

39.6 (11.6)

40.8 (10.3)

1.01; 0.99–1.03; p = 0.17

Sex

 Male

277 (40.8)

89 (32.1)

188 (67.9)

1

40 (14.4)

237 (85.6)

1

48 (17.3)

229 (82.7)

1

217 (78.3)

60 (21.7)

1

 Female

395 (58.1)

129 (32.7)

266 (67.3)

0.97; 0.69–1.38; p = 0.89

56 (14.2)

339 (85.8)

0.94; 0.59–0.48; p = 0.80

82 (20.8)

313 (79.2)

0.81; 0.54–1.22; p = 0.32

316 (80.0)

79 (20.0)

0.93; 0.63–1.39; p = 0.75

 Intersex

3 (0.4)

2 (66.7)

1 (33.3)

0.67; 0.04–9.71; p = 0.77

1 (33.3)

2 (66.7)

0.56; 0.03–0.87; p = 0.68

1 (33.3)

2 (66.7)

0.53; 0.03–7.87; p = 0.64

2 (66.7)

1 (33.3)

3.30; 0.22–49.46; p = 0.38

Decline to answer

5 (0.7)

1 (20.0)

4 (80.0)

1.72; 0.18–15.82; p = 0.62

2 (40.0)

3 (60.0)

0.20; 0.03–0.29; p = 0.09

1 (20.0)

4 (80.0)

0.96; 0.10–8.94; p = 0.97

5 (100.0)

0 (0.0)

Not calculated (p = 0.99)

Educational level

No formal

24 (3.5)

20 (83.3)

4 (16.7)

0.66; 0.02–0.20; p < 0.01

8 (33.3)

16 (66.7)

0.30; 0.11–0.79; p = 0.01

6 (25.0)

18 (75.0)

0.49; 0.17–1.39; p = 0.18

21 (87.5)

3 (12.5)

0.24; 0.06–0.89; p = 0.03

Primary

57 (8.4)

30 (52.6)

27 (47.4)

0.34; 0.19–0.60; p < 0.01

14 (24.6)

43 (75.4)

0.43; 0.21–0.87; p = 0.01

12 (21.1)

45 (78.9)

0.78; 0.38–1.60; p = 0.50

53 (93.0)

4 (7.0)

0.19; 0.06–0.55; p < 0.01

Secondary

239 (35.1)

72 (30.1)

167 (69.9)

0.94; 0.65–1.36; p = 0.75

31 (13.0)

208 (87.0)

0.96; 0.58–1.59; p = 0.89

51 (21.3)

188 (78.7)

0.82; 0.53–1.26; p = 0.37

203 (84.9)

36 (15.1)

0.53; 0.34–0.82; p < 0.001

Tertiary

360 (52.9)

99 (27.5)

261 (72.5)

1

46 (12.8)

314 (87.2)

1

63 (17.5)

297 (82.5)

1

263 (73.1)

97 (26.9)

1

Depression

 No

52 (81.2)

177 (32.1)

375 (67.9)

1

86 (15.6)

466 (84.4)

1

124 (22.5)

428 (77.5)

1

453 (82.1)

99 (17.9)

1

 Yes

128 (18.8)

44 (34.4)

84 (65.6)

1.09; 0.70–1.69; p = 0.70

13 (10.2)

115 (89.8)

1.90; 0.99–3.68; p = 0.05

8 (6.3)

120 (93.7)

4.80; 2.24–10.27; p < 0.01

87 (68.0)

41 (32.0)

2.10; 1.33–3.31; p < 0.01

  1. ART antiretroviral therapy